首页> 外文OA文献 >Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COP

【2h】

Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COP

机译：72岁患者临床缓解患者含有巨大的主要皮肤外周T细胞淋巴瘤 - 眼睑NOS，之后与依托泊苷加上COP组合化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Sabina Iluta; Dragos-Alexandru Termure; Bobe Petrushev; Bogdan Fetica; Mindra-Eugenia Badea; Madalina Moldovan-Lazar; Manuela Lenghel; Csaba Csutak; Andrei Roman; Sergiu Pasca; Alina-Andreea Zimta; Ciprian Jitaru; Ciprian Tomuleasa; Rares-Calin Roman;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Primary cutaneous peripheral T-cell lymphoma, unspecified with an indolent clinical course: a distinct peripheral T-cell lymphoma? [J] . Ryan AJ, Robson A, Hayes BD, Clinical and experimental dermatology . 2010,第8期

机译：原发性皮肤周围性T细胞淋巴瘤，无特殊的临床病程：独特的周围性T细胞淋巴瘤？
2. Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressiv [J] . Rodel S, Engert A, Diehl V, Leukemia and lymphoma . 2005,第12期

机译：阿霉素，环磷酰胺，长春新碱，氨甲蝶呤，依托泊苷和地塞米松（ACOMED）联合化疗，然后进行野外放疗，可提高侵略性患者的缓解率和长期长期生存率
3. Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement [J] . Chan Kah-Lok, van der Weyden Carrie, Khoo Christine, Leukemia and lymphoma . 2017,第3a4期

机译：ROMIDEPSIN诱导耐用的临床缓解，用于化疗 - 难治性外周T细胞淋巴瘤，中枢神经系统受累
4. ELEVATION OF MINIMAL RESIDUAL DISEASE (MRD) IN THE PERIPHERAL BLOOD PRIOR TO THE CLINICAL RELAPSE IN DOGS WITH LYMPHOMA THAT ACHIEVED COMPLETE REMISSION AFTER CHEMOTHERAPY [C] . Masahiko Sato, Junpei Yamazaki, Yuko Goto-Koshino, Annual Conference of the Veterinary Cancer Society . 2009

机译：在淋巴瘤患者临床复发之前在外周血中的最小残留疾病（MRD）升高，从而在化疗后取得完全缓解
5. Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid Following Combination Chemotherapy with Etoposide Plus COP [O] . Sabina Iluta, Dragos-Alexandru Termure, Bobe Petrushev, 2020

机译：72岁患者临床缓解患者含有巨大的主要皮肤外周T细胞淋巴瘤 - 眼睑NOS之后与依托泊苷加上COP组合化疗
6. Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or naturalkiller/T-cell lymphoma. [O] . Tiffany Tang, Peter Martin, Nagavalli Somasundaram, 2020

机译：I阶段研究Selinexor与地塞米松，Ifosfamide，Carboplatin，复发或难治性外周T细胞或Naturalkiller / T细胞淋巴瘤患者的依托普齐德化疗。

Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COP

著录项

相似文献

相关主题

期刊订阅